Joseph Kim is a Professor of Surgery and Chief of Surgical Oncology at the UK Markey Cancer Center. He is a scientist and entrepreneur who has been involved in cancer vaccine development at Inovio Pharmaceuticals, a company focusing on DNA-based immunotherapies.